Please use this identifier to cite or link to this item:
Title: BRAF Mutations-A Good News Story for Immune Checkpoint Inhibitors in Oncogene-Addicted NSCLC?
Austin Authors: Arulananda, Surein;Mitchell, Paul L R 
Affiliation: Cancer Immuno-Biology Laboratory, Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia
School of Cancer Medicine, La Trobe University, Heidelberg, Australia
Department of Medical Oncology, Austin Health, Heidelberg, Victoria, Australia
Department of Medicine, University of Melbourne, Parkville, Australia
Issue Date: Aug-2018 2018-07-02
Publication information: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2018; 13(8): 1055-1057
DOI: 10.1016/j.jtho.2018.06.002
ORCID: 0000-0002-5636-6381
PubMed URL: 30056857
Type: Journal Article
Appears in Collections:Journal articles

Show full item record

Page view(s)

checked on Nov 28, 2022

Google ScholarTM


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.